A community outreach intervention to link individuals with opioid use disorders to medication-assisted treatment
A community outreach intervention to link individuals with opioid use disorders to medication-assisted treatment
复制标题
DOI：
10.1016/j.jsat.2019.07.001
复制
发表时间：
2020-01-01
影响因子：
3.9
通讯作者：
Funk, Rodney R.
中科院分区：
文献类型：
--
作者：
Scott, Christy K.;Dennis, Michael L.;Funk, Rodney R.
阿片类药物使用障碍（OUD）患者在获得药物辅助治疗（MAT）方面面临重大障碍，但获得MAT对于减少阿片类药物相关死亡至关重要。本研究评估了芝加哥的同伴外展和治疗联系干预，该干预是伊利诺伊州阿片类药物州目标反应（STR）项目的一部分，旨在帮助OUD患者获得MAT。该研究使用阿片类药物使用障碍级联护理的框架来跟踪干预的连续阶段的进展，并评估了各个阶段成功过渡的协变量。同伴外展工作人员联系了高危社区的个人，进行了资格筛选，并安排符合条件的个人与项目工作人员会面以进行治疗联系。在12个月的研究期间（2017年7月至2018年6月），同伴外展工作者与个人进行了大约3308次接触；83% （n = 1638）被确定符合干预条件，并同意召开现场联动会议。其中大多数（59%,n = 972）参加了联动会议；其中大多数（92%,n = 890）被安排参加MAT的入学预约；86% （n = 765）的被安排参加MAT的入学预约。大多数（91%;n = 696）接受治疗的患者接受了首次剂量，其中72% （n = 498）在首次剂量后30天仍在接受治疗。一些参与者的特征区分了在级联模型的每个阶段继续的个体和没有继续的个体。这些发现表明，同伴外展和治疗联动干预可以成功地使OUD患者参与治疗。
Individuals with opioid use disorders (OUD) face significant barriers to accessing medication-assisted treatment (MAT), yet access to MAT is critical to reducing opioid-related fatality. This study evaluated a peer outreach and treatment linkage intervention in Chicago that is part of the Illinois Opioid State Targeted Response (STR) project to assist individuals with OUD in accessing MAT. The study uses the framework of the Opioid Use Disorder Cascade of Care to track progress through successive stages of the intervention and evaluated covariates of successful transitions across stages. Peer outreach workers contacted individuals in high-risk communities, conducted an eligibility screen, and scheduled eligible individuals to meet with project staff for treatment linkage. Over the 12-month study period (July 2017-June 2018), peer outreach workers conducted approximately 3308 encounters with individuals; 83% (n = 1638) were determined to be eligible for the intervention and agreed to an on-site linkage meeting. A majority of these (59%; n = 972) showed to the linkage meeting; most of these (92%, n = 890) were scheduled for a MAT intake appointment; and 86% (n = 765) of those scheduled showed to the MAT intake appointment. Most (91%; n = 696) of those who showed for treatment intake received a first dose, and 72% (n = 498) of these were in treatment at 30 days after their first dose. Several participant characteristics differentiated individuals that continued at each stage of the cascade model from those that did not. These findings demonstrate that the peer outreach and treatment linkage intervention may be successfully used to engage individuals with OUD into treatment.